Literature DB >> 8795371

Excimer laser photorefractive keratectomy for patients with contact lens intolerance caused by dry eye.

I Toda1, Y Yagi, S Hata, S Itoh, K Tsubota.   

Abstract

AIMS/
BACKGROUND: To evaluate epithelial wound healing and visual outcome of excimer laser photorefractive keratectomy (PRK) performed on high myopic eyes with contact lens intolerance due to dry eye.
METHODS: PRK was performed on two groups of patients with non-Sjogren's dry eye: group A (-6 D to -9.5 D, 11 patients, 17 eyes) and group B (-11.5 D to -19.5 D, 11 patients, 16 eyes) in an attempt to eliminate the use of contact lenses (CL). The intended correction was full in group A and 10 D in group B.
RESULTS: Uncorrected visual acuity in group A was better than 20/40 in 12 (80.0%) of 15 eyes at 6 months and in 10 (90.9%) of 11 eyes at 1 year. Fourteen (92.8%) of 17 eyes in group A and four (25.0%) of 16 eyes in group B achieved refraction within plus or minus 1 D of the intended correction at 6 months. Re-epithelialisation was complete in 4 days, and epithelial cell area and permeability returned to the preoperative level within 1 month in all cases. All patients in group A were able to eliminate CL, whereas in group B, one patient needed spectacles for residual myopia and two patients resumed CL use because of regression. One eye with severe subepithelial scar formation and one eye with macular haemorrhage were observed in group B.
CONCLUSION: Our results suggest that PRK is effective for patients with high myopia (-6 D to approximately -10 D) and CL intolerance due to dry eye. Further studies are required to improve predictability and to prevent complications in PRK for very high myopia (> -10 D).

Entities:  

Mesh:

Year:  1996        PMID: 8795371      PMCID: PMC505553          DOI: 10.1136/bjo.80.7.604

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  31 in total

1.  The importance of the Schirmer test with nasal stimulation.

Authors:  K Tsubota
Journal:  Am J Ophthalmol       Date:  1991-01-15       Impact factor: 5.258

2.  Wound healing after excimer laser keratomileusis (photorefractive keratectomy) in monkeys.

Authors:  F E Fantes; K D Hanna; G O Waring; Y Pouliquen; K P Thompson; M Savoldelli
Journal:  Arch Ophthalmol       Date:  1990-05

3.  A contact lens for specular microscopic observation.

Authors:  K Tsubota
Journal:  Am J Ophthalmol       Date:  1988-11-15       Impact factor: 5.258

4.  Excimer laser surgery of the cornea.

Authors:  S L Trokel; R Srinivasan; B Braren
Journal:  Am J Ophthalmol       Date:  1983-12       Impact factor: 5.258

5.  An in vivo study of corneal surface morphologic features in patients with keratoconjunctivitis sicca.

Authors:  M A Lemp; J B Gold; S Wong; M Mahmood; R Guimaraes
Journal:  Am J Ophthalmol       Date:  1984-10-15       Impact factor: 5.258

6.  Contact lenses and other risk factors in microbial keratitis.

Authors:  J K Dart; F Stapleton; D Minassian
Journal:  Lancet       Date:  1991-09-14       Impact factor: 79.321

Review 7.  Is the dry eye contact lens wearer at risk? Yes.

Authors:  M A Lemp
Journal:  Cornea       Date:  1990       Impact factor: 2.651

8.  Corneal wound healing after 193-nm excimer laser keratectomy.

Authors:  W C Wu; W J Stark; W R Green
Journal:  Arch Ophthalmol       Date:  1991-10

9.  Ocular fatigue is the major symptom of dry eye.

Authors:  I Toda; H Fujishima; K Tsubota
Journal:  Acta Ophthalmol (Copenh)       Date:  1993-06

10.  Retinol secretion by the lacrimal gland.

Authors:  J L Ubels; K M Foley; V Rismondo
Journal:  Invest Ophthalmol Vis Sci       Date:  1986-08       Impact factor: 4.799

View more
  2 in total

1.  Treatment of dry eye by autologous serum application in Sjögren's syndrome.

Authors:  K Tsubota; E Goto; H Fujita; M Ono; H Inoue; I Saito; S Shimmura
Journal:  Br J Ophthalmol       Date:  1999-04       Impact factor: 4.638

2.  Albumin as a tear supplement in the treatment of severe dry eye.

Authors:  S Shimmura; R Ueno; Y Matsumoto; E Goto; A Higuchi; J Shimazaki; K Tsubota
Journal:  Br J Ophthalmol       Date:  2003-10       Impact factor: 4.638

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.